Pear Therapeutics raises $20M for digital therapeutics portfolio aimed at substance abuse, schizophrenia
Pear Therapeutics received equity finance backing from a group of investors with 5AM Ventures, Arboretum Ventures, and JAZZ Venture Partners leading the round.